Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Liverpool Echo
Liverpool Echo
World
Florence Freeman & Christopher Megrath

Male contraceptive pill created in 'game changing' development

A new, male contraceptive pill has been developed designed to block fertility protein for 24 hours.

Scientists said the new medication is more effective than female birth control pills which have to be taken daily. The pill is designed to disable an enzyme called sAC (soluble adenylyl cyclase) which triggers sperm cells to swim.

Experiments saw male and female lab rodents mating but none resulted in pregnancy, with 52 attempts failing. A single dose rendered sperm immobile for up to two-and-a-half hours - with the effects persisting in the female reproductive tract after sex.

READ MORE: Martin Lewis warning to anyone going abroad in 2023

Lead author Dr Melanie Balbach said: "Our inhibitor works within 30 minutes to an hour. Every other experimental hormonal or non-hormonal male contraceptive takes weeks to bring sperm count down or render them unable to fertilise eggs."

"Sperm recovered from female mice remained incapacitated. There were no side effects. The compound wore off three hours later, and males recovered their fertility."

The team at Weill Cornell Medicine, New York, hailed the breakthrough as a potential "gamechanger". For years scientists have worked to develop an effective male oral contraceptive, the Mirror reported.

Previous contraceptives had led to obesity, depression and high cholesterol. Women's choices range from pills to patches to intrauterine devices but they bear most of the burden of preventing pregnancy.

There are only two contraceptives for men currently - condoms or a vasectomy. Condoms are only single-use and prone to failure. A vasectomy is a surgical sterilisation that's expensive to reverse and not always successful.

It takes weeks to reverse the effects of other hormonal and non-hormonal male contraceptives in development, said Dr Balbach. It could also allow men to make day-to-day decisions about their fertility.

Co-author Professor Lonny Levin said: "The team is already working on making sAC inhibitors better suited for use in humans." The team said it planned on repeating its study in a different pre-clinical model to lay the groundwork for clinical trials.

It would test the effect on sperm motility in healthy human males. Prof Levins said he hopes to walk into a pharmacy one day and hear a man request "the male pill".

READ NEXT

Receive newsletters with the biggest and breaking TV and showbiz news by signing up here

For more celeb news, videos and pictures follow our designated Facebook page HERE

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.